Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Targeting the TLK1/NEK1 axis in prostate cancer

US Patent 11826369 · Granted Nov 28, 2023

Estimated economic value: $549,000

Assignee

Inventors

View full patent text on Google Patents →